加药
医学
药代动力学
药效学
麻醉剂
麻醉
体重
人口
肥胖
瘦体质量
药理学
内科学
环境卫生
作者
Kai Mo,Shiyuan Xu,Zhongjie Liu,Fengxian Li,Qi-bo Liang,Qingguo Zhang
出处
期刊:International Journal of Anesthesiology and Resuscitation
[Chinese Medical Association]
日期:2013-06-15
卷期号:34 (06): 537-540
标识
DOI:10.3760/cma.j.issn.1673-4378.2013.06.015
摘要
Background Obese patients have greater inter-individual variations than the standard-size patients in the anesthetic pharmacokinetics and pharmacodynamics.In obese population,changes in cardiac output and alterations in body composition affect the distribution of numerous anaesthetics,therefore,administration of drugs based on total body weight could result in overdose,conversely,administration of drugs based on ideal body weight could result in an inadequate dose.Objective This review focuses on the pharmacokinetics and pharmacodynamics properties of intravenous anesthetic in obese patients in order to provide recommendation for rational application of intravenous anesthetic in obese patients and reduce complications.Content Discussing dosing scalars based on total body weight,ideal body weight,body surface area and lean body weight as well as its recent advances in clinical application of intravenous anaesthetics in the obese.Trend To avoid postoperative residual curarization,the ideal body weight might be appropriate for dosing scalar of the non-depolarizing neuromuscular blocking agents,whereas,lean body weight is the optimal dosing scalar for the majority of anaesthetic agents including opioids and anaesthetic-induction agents for obese patients.
Key words:
Obesity; Anaesthetics; Pharmacokinetics; Pharmacodynamics
科研通智能强力驱动
Strongly Powered by AbleSci AI